InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: Wolverine3 post# 360

Friday, 05/12/2023 10:00:40 AM

Friday, May 12, 2023 10:00:40 AM

Post# of 575
One of the key drivers of resistance to Gilteritinib is Ras. Both Lux and Tusp appear to be effective against Ras. This stuff leads to potential DOR benefit. Huge value.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News